[1]Patent:WO2004/41829,2004,A1.Locationinpatent:Page64
[2]Patent:WO2004/69249,2004,A1.Locationinpatent:Page/Pagecolumn57
[1]Patent:WO2003/103668,2003,A1.Locationinpatent:Page23
[1]Patent:EP1548008,2005,A1.Locationinpatent:Page/Pagecolumn121
[1]InorganicChemistry,2003,vol.42,p.3576-3581
Title: Pyrimidin-2(1H)-ones based inhibitors of Mycobacterium tuberculosis orotate phosphoribosyltransferase.
Journal: European journal of medicinal chemistry 20120801
Title: Proteomic differential display analysis for TS-1-resistant and -sensitive pancreatic cancer cells using two-dimensional gel electrophoresis and mass spectrometry.
Journal: Anticancer research 20110601
Title: Antineoplastic Activity of New Transition Metal Complexes of 6-Methylpyridine-2-carbaldehyde-N(4)-ethylthiosemicarbazone: X-Ray Crystal Structures of [VO(2)(mpETSC)] and [Pt(mpETSC)Cl].
Journal: Bioinorganic chemistry and applications 20100101
Title: Experimental study of combination therapy with S-1 against pancreatic cancer.
Journal: Cancer chemotherapy and pharmacology 20091101
Title: Synthesis, Spectroscopic, and Anticancerous Properties of Mixed Ligand Palladium(II) and Silver(I) Complexes with 4,6-Diamino-5-hydroxy-2-mercaptopyrimidine and 2,2'-Bipyridyl.
Journal: Metal-based drugs 20080101
Title: Synergistic antitumor effect of combined 5-fluorouracil (5-FU) with 5-chloro-2,4-dihydroxypyridine on 5-FU-resistant gastric cancer cells: possible role of a dihydropyrimidine dehydrogenase-independent mechanism.
Journal: Journal of gastroenterology 20071001
Title: Role of dihydropyrimidine dehydrogenase inhibitory fluoropyrimidine against non-small cell lung cancer--in correlation with the tumoral expression of thymidylate synthase and dihydropyrimidine dehydrogenase.
Journal: Lung cancer (Amsterdam, Netherlands) 20050701
Title: Phase I and pharmacokinetic study of the oral fluoropyrimidine S-1 on a once-daily-for-28-day schedule in patients with advanced malignancies.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20040801
Title: The effect of food on the pharmacokinetics of S-1 after single oral administration to patients with solid tumors.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20040615
Title: Pharmacokinetics of S-1, an oral formulation of ftorafur, oxonic acid and 5-chloro-2,4-dihydroxypyridine (molar ratio 1:0.4:1) in patients with solid tumors.
Journal: Cancer chemotherapy and pharmacology 20030701
Title: [Concentration of FT and CDHP and 5-FU in the ascites fluid of patient with peritoneal carcinomatosis after new anti-cancer drug TS-1 oral administration].
Journal: Gan to kagaku ryoho. Cancer & chemotherapy 20020701
Title: Enhancement of the antitumour activity of 5-fluorouracil (5-FU) by inhibiting dihydropyrimidine dehydrogenase activity (DPD) using 5-chloro-2,4-dihydroxypyridine (CDHP) in human tumour cells.
Journal: European journal of cancer (Oxford, England : 1990) 20020601
Title: Increased intestinal permeability correlates with gastrointestinal toxicity among formulations of the fluorouracil analogue tegafur in rats.
Journal: European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes 20020101
Title: Fluorouracil (5FU) pharmacokinetics in 5FU prodrug formulations with a dihydropyrimidine dehydrogenase inhibitor.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20011115
